Session Learning Objectives:
1. Describe the goals of public health newborn screening;
2. Describe limitations of using DNA sequencing for predicting disease;
3. Describe an example of the clinical utility of DNA sequencing for newborn screening.

Presenters:
Wendy K. Chung, MD, PhD
Chief, Department of Pediatrics
Boston Children's Hospital

Dr. Chung has disclosed the following financial relationships:
Illumina (in kind funder)
GeneDx (in kind funder)

She does not plan on discussing unlabeled/investigational uses of a commercial product.